Baxter International and Nycomed have announced that TachoSil (absorbable fibrin sealant patch) has been approved as an adjunct to hemostasis for use in cardiovascular surgery when control of bleeding by standard surgical techniques (eg, suture, ligature, or cautery) is ineffective or impractical. TachoSil combines a collagen patch with a coating of human coagulation factors and can be applied to the bleeding area either dry or wet. In the presence of saline, blood, or other bodily fluids, the coagulation factors dissolve to form a fibrin clot, which adheres the TachoSil patch to the bleeding surface and achieves hemostasis.
TachoSil is expected to be made available in the second half of 2010.
For more information visit www.nycomed.com.